Collaboration Highlights UCSF Cancer Center's Leadership in Precision Medicine for Prostate Cancer

A new collaboration between the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC) and the biotechnology company Strata Oncology to provide free genomic testing to men with advanced prostate cancer could help patients nationwide gain access to cutting-edge treatment and lead to new therapies for one of the most prevalent cancers in men.

To read the full article click here